個人投資家向けデータ API 配信サービス「 J-Quants API 」の Python クライアントライブラリです。 J-Quants や API 仕様についての詳細を知りたい方は 公式ウェブサイト をご参照ください。 現在、J ...

SIL determination is a site-specific, process-specific analysis, and under IEC 61511, it is the process owner’s responsibility to carry it out with rigor. Under IEC 61511, SIL (Safety Integrity Level) ...

My favorite kind of vintage purchase is one that comes with a rich history. Take the Zac Posen dress I found at last year’s Vogue Vintage Market, worn by Laura Love to her prom in the late aughts, ...

Global X Silver Miners ETF offers leveraged exposure to silver’s cyclical upswings, benefiting from operational leverage as metal prices surge. SIL’s concentrated portfolio—top ten holdings at ...

GDX comes in more affordable with a 0.51% expense ratio, undercutting SIL’s 0.65%, but also pays a lower dividend yield at 0.5% versus SIL’s 1% -- a modest difference for income-focused investors.

Although you would never know it from reading the headlines, silver has left gold in the dust over the past few years. In fact, over the past decade, the white metal has outperformed its yellow rival, ...

Some facts about proof test coverage and how it affects safety integrity level calculations. When designing or verifying a safety instrumented function (SIF), it’s common to hear terms such as PFDavg ...

Traders who code have an edge – Python skills are helping traders automate tasks and improve accuracy. Automation is solving workflow pain points – Leading firms are cutting manual steps and boosting ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating inhibition of tumor growth in a clinically relevant orthotopic model; Further ...

(RTTNews) - Silexion Therapeutics Corp. (SLXN), a clinical-stage biotechnology company, announced Tuesday significant preclinical data for SIL-204, its next-generation siRNA therapeutic candidate ...

Galeterone monotherapy in advanced pancreatic ductal adenocarcinoma: Results from a phase two trial. Immunotherapy engagement in pancreatic adenocarcinoma: Provisional results of iLSTA study— ...